Fines and settlements this week

Discussion in 'Novartis' started by anonymous, Mar 5, 2019 at 5:33 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    This week saw NVS fined 23 million in Medicare kickbacks. It also was the week where the brave Min Amy Guo was awarded 1.5 million by a jury. Amy was fired for something she believed in. Her boss who went with the company and fired her was made CSO, China. NVS during the current oncology layoffs laid off several excellent employees due to their fear of similar retribution. Cases are being created against People who were performing well only to avoid such lawsuits. Amy Guo, you were gutsy and fought this to the very end and had a lawyer who believed in her and took it to the very end. NVS continues to keep people who are not worth a dollar they are receiving.
     

  2. anonymous

    anonymous Guest

    I find it interesting when there is a settlement there is little discussion or concern. Business as usual? Any updates on that big Hooters lawsuit from NY. It has been going on for years
     
  3. anonymous

    anonymous Guest

    No one wants to get their hands dirty in the filth. They might be targeted so better to stay away.
     
  4. anonymous

    anonymous Guest

    Wait more will settled very soon. The old BPO system was flawed and could not handle all the incoming complaints from employees. The new team will be much different and will have lawyers' reviewing cases.
     
  5. anonymous

    anonymous Guest

    Left
    This is the kind of nonsense that’s going on for years. This person never really wanted to move as CSO, China but that was the only position offered. She has her cronies here who are reporting everything going on daily to her if not hourly. So much crap is under the surface.
     
  6. anonymous

    anonymous Guest

    Did NVS have a good reputation at one point or is it just my imagination/koolaid? The efficacy data for most drugs is subpar and the safety profile for the ok drugs are pretty bad. There are several pending lawsuits but one particular one is a pretty bad safety issue. It is under investigation but will there be a fine or do we have the FDA in our pockets as usual.
     
  7. anonymous

    anonymous Guest

    The old BPO was covering up stuff and investigators who did not agree to this were all fired and new brit cops brought in to carry on the coverup.....Global security is run by Brit police and now intelligence and their only job is to cover up
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    The Oswald Bilotta case is scheduled to go to court in Manhattan on May 20, 2019. I hope to see you there.
     
  11. anonymous

    anonymous Guest

    Are you going to wave so we know it's you?
     
  12. anonymous

    anonymous Guest

    It just seems Novartis has so much to lose if it goes to trial and they lose since they were under a CIA. Probably will settle after earnings call this week.
     
  13. anonymous

    anonymous Guest

    100% fact. Three recent investigations which were clearly on the right track got derailed. So much for ethics. Medical is just bad.
     
  14. anonymous

    anonymous Guest

    “Sandoz conspired for years with other manufacturers and their executives to raise prices for critical medications, and the Antitrust Division will continue its ongoing investigation to hold both individuals and corporations accountable,” said Makan Delrahim, head of the Justice Department’s Antitrust Division.

    Wow it never ends, greed and stupidity is the definition of Novartis
     
  15. anonymous

    anonymous Guest

    #MuhLegacy :rolleyes:

    Novartis shells out $195M to settle criminal charges in generics price-fixing probe
    by
    Kyle Blankenship |
    Mar 2, 2020 6:12pm

    Novartis is the single largest player bagged as part of the Department of Justice's yearslong generics price-fixing probe. (Novartis)
    agreed Tuesday to pay $195 million and enter deferred prosecution to settle federal claims it colluded in an industrywide price-fixing scheme between 2013 and 2015, the U.S. Department of Justice (DOJ) said.

    The criminal settlement is the single largest domestic antitrust deal ever signed, the DOJ said in a release, and it comes two weeks after a former Sandoz unit exec pleaded guilty to federal conspiracy charges in the scheme.
     
  16. anonymous

    anonymous Guest

    maybe now Sandoz can close the Aurobindo deal... :p
     
  17. anonymous

    anonymous Guest

    BPO didn’t make a move without the blessing of the HR partners and Sam Rini. BPO did what they were told. BPO is just there for show. If there is an investigation that is exactly what witnesses will say, what BPO will say, and what phone records and emails will prove.
     
  18. anonymous

    anonymous Guest

    Settlements allow Novartis to further coverup their infringements. Justice needs to be seen to be done and the public has a right to know the dirty details of Novartis behavior.
     
  19. anonymous

    anonymous Guest

    The Oswald Bilotta case has already settled. It is mentioned on other threads. 700 million dollars . They are once again working on yet another new corporate integrity agreement. Being a whistleblower is a very hard and a noble thing to do. It takes a lot of guts and work. Oswald is about to be rewarded for his hard work and ethics.